Intra-individual variability in serum creatinine levels and estimated glomerular filtration rate (eGFR) over 3 years was independently associated with the presence as well as the severity of diabetic retinopathy (DR) in patients with type 2 diabetes (T2D), indicating that variability in these biomarkers can serve as predictors to identify T2D patients at risk of DR, suggests a local study.
Children spending longer hours in cram school are at greater risk of myopia, with the effect attributed to increased time doing near visual activity or reduced time spent outdoors, a Taiwan study has found.
Treatment with adalimumab leads to quiescence, improved visual acuity and reduced daily uveitis-related systemic corticosteroid use in patients with active uveitis and sustained quiescence without a systemic corticosteroid dose increase among those with inactive uveitis at study entry, results of the VISUAL III trial have shown. Additionally, no new safety signals are found.
Intravitreal aflibercept injection appears to be safe and effective in the treatment of polypoidal choroidal vasculopathy, producing improvements in visual and/or functional outcomes without any signs of leakage lesions in most patients, according to the results of the PLANET study.
Children in Singapore were exposed to significantly less outdoor light daily than children in Australia, which could contribute to the higher prevalence of myopia among Singapore children compared with their Australian counterparts, suggests a study.
Individuals with diabetes or long-term hyperglycaemia appear to have higher intraocular pressure (IOP), with central corneal thickness representing a meagre proportion of mediating effect to the total effect of diabetes on IOP, according to a cross-sectional study from Singapore.
Silent reading for as little as 30 minutes may induce measurable changes on the tear film and ocular surface in individuals at least 50 years of age, especially in those with dry eye, a study has found.
In the treatment of proliferative diabetic retinopathy (DR), eyes gain vision and rarely develop vision-impairing central-involved diabetic macula oedema (DME) over 2 years with ranibizumab, according to a posthoc analysis. In contrast, factors such as poor glycaemic control and more severe DR increase the likelihood of losing visual acuity and developing DME following panretinal photocoagulation (PRP).